Terms: = Liver cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Clinical Outcome
3 results:
1. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
[TBL] [Abstract] [Full Text] [Related]
2. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance.
Knöll A; Hartmann A; Hamoshi H; Weislmaier K; Jilg W
World J Gastroenterol; 2006 Feb; 12(8):1255-60. PubMed ID: 16534880
[TBL] [Abstract] [Full Text] [Related]
3. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
Ng KK; Poon RT; Lo CM; Liu CL; Lam CM; Ng IO; Fan ST
Arch Surg; 2004 Feb; 139(2):193-200. PubMed ID: 14769580
[TBL] [Abstract] [Full Text] [Related]
